Evercore ISI Group Maintains Outperform on Abbott Laboratories, Lowers Price Target to $120

Benzinga Newsdesk www.benzinga.com Negative 94.7%

Neg 94.7% Neu 0% Pos 0%

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from $134 to $120.